Request Deal Involvement

An investor consortium led a $351m Series D round in Eikon Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Bioscribe

pr advisors

Bioscribe

or

Principals

EIKON THERAPEUTICS INC

target

EIKON THERAPEUTICS INC

LUX CAPITAL MANAGEMENT

bidder

LUX CAPITAL MANAGEMENT

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

AME CLOUD VENTURES

bidder

AME CLOUD VENTURES

THE COLUMN GROUP

bidder

THE COLUMN GROUP

E15 VC

bidder

E15 VC

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

GENERAL CATALYST PARTNERS

bidder

GENERAL CATALYST PARTNERS

SOROS FUND MANAGEMENT LLC

bidder

SOROS FUND MANAGEMENT LLC

STEPSTONE GROUP

bidder

STEPSTONE GROUP

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

UC INVESTMENTS

bidder

UC INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite